Pulse Biosciences (PLSE) Revenue (2021 - 2026)

Pulse Biosciences (PLSE) posted Revenue of $434000.0 for Q2 2026, up 64.39% on a QoQ basis from $264000.0 in Q4 2025.

Analysis

Pulse Biosciences (PLSE) Revenue (2021 - 2026) Analysis & Trends

Pulse Biosciences has reported Revenue for 4 years, with the latest figure at $434000.0 in Q2 2026.

On a quarterly basis, Revenue changed N/A year-over-year to $434000.0 in Q2 2026; TTM through Jun 2026 was $784000.0, a N/A change from a year earlier, with the FY2025 full-year figure at $350000.0, changed N/A from the prior year.
Revenue was $434000.0 for Q2 2026 at Pulse Biosciences, up from $264000.0 in the prior quarter.
The five-year high for Revenue was $444000.0 in Q1 2022, with the low at -$9000.0 in Q4 2022.
Average Revenue over 3 years is $253166.7, with a median of $282000.0 recorded in 2022.
The largest YoY upside for Revenue was 101.07% in 2022 against a maximum downside of 101.07% in 2022.
Over 3 years, Revenue stood at -$9000.0 in 2022, then jumped by 3033.33% to $264000.0 in 2025, then jumped by 64.39% to $434000.0 in 2026.
The last three Revenue figures came in at $434000.0 (Q2 2026), $264000.0 (Q4 2025), and $86000.0 (Q3 2025), per Business Quant data.

Peer Set

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Revenue (Qtr)
1	Abbott Laboratories	179.79 Bn	174.18 Bn	7.27 Bn	12.59 Bn
2	Intuitive Surgical	127.69 Bn	122.47 Bn	1.96 Bn	2.89 Bn
3	Medtronic	117.23 Bn	108.41 Bn	6.34 Bn	9.76 Bn
4	Stryker	103.55 Bn	100.07 Bn	4.50 Bn	6.59 Bn
5	Boston Scientific	63.24 Bn	62.70 Bn	3.85 Bn	5.44 Bn
6	Edwards Lifesciences	49.97 Bn	45.72 Bn	1.35 Bn	1.74 Bn
7	Alcon	32.83 Bn	31.37 Bn	1.68 Bn	2.78 Bn
8	Dexcom	32.30 Bn	30.35 Bn	830.00 Mn	1.31 Bn
9	Steris	20.73 Bn	20.25 Bn	684.20 Mn	1.49 Bn
10	Pulse Biosciences	3.76 Bn	3.76 Bn	161,000.00	434,000.00

Historic Data

Download Data